AKT1 and neoplasm: Another widely reported component of PSORI-CM02 that blocks the mTOR pathway is isorhamnetin, which is known to repress the proliferation of various tumor cells by inhibiting the PI3K/AKT/mTOR pathway (Li et al., 2014; Hu et al., 2015; Cai et al., 2020).